Have a personal or library account? Click to login
The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer Cover

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer

Free to read
|Jul 2016

Figures & Tables

Figure 1

Progression free survival of patients after primary surgery and neoadjuvant chemotherapy (NACT).
Progression free survival of patients after primary surgery and neoadjuvant chemotherapy (NACT).

Figure 2

Overall survival of patients after primary surgery and neoadjuvant chemotherapy (NACT).
Overall survival of patients after primary surgery and neoadjuvant chemotherapy (NACT).

Figure 3

Survival curves of patients after different surgical outcomes.NACT = neoadjuvant chemotherapy; R0 = no macroscopic residual disease; R1= < 1 cm residual disease; R2= >1 cm residual disease
Survival curves of patients after different surgical outcomes.NACT = neoadjuvant chemotherapy; R0 = no macroscopic residual disease; R1= < 1 cm residual disease; R2= >1 cm residual disease

Five-year and eight-year survival of patients after different surgical outcomes

Five-year survivalEight year survivalp
Surgery - R0 resection62.5%62.5%P < 0.0001
NACT -R0 resection20.6%17.1%
Surgery - R1 resection38.9%27.8%P < 0.0001
NACT -R1 resection16.7%11.1%
Surgery - R2 resection15.5%0%P < 0.0001
NACT -R2 resection0%0%
Inoperable disease0%0%-

Factors correlated with survival on multivariate analysis

p
Age (years)
                                        < 600.775
                                        ≥ 60
Histology
                                        High grade serous0.370
                                        Other histology
Performance status
                                        0 or 1
                                        > 10.003
Extent of residual disease
                                        R0
                                        R1< 0.0001
                                        R2
Therapy
                                        Primary surgery
                                        NACT0.038

The characteristics of patients and surgical outcomes

Primary surgery N = 80NACT N = 80p
Age (years)60.264.80.006
High grade serous43 (54%)53 (66%)0.307
Performance 0 or 166 (83%)32 (40%)< 0.0001
                                                    >114 (17%)48 (60%)
R0 resection16 (20%)34 (42%)0.011
R1 resection18 (23%)18 (22%)1.0
R2 resection46 (57%)11 (14%)< 0.0001
Inoperable-17 (21%)-
PFS (months)17.714.10.213
OS (months)31.624.80.012

Factors correlated with survival on univariate analysis

p
Age (years)
                                        < 600.008
                                        ≥ 60
Histology
                                        High grade serous0.066
                                        Other histology
Performance status
                                        0 or 1
                                        > 1< 0.0001
Extent of residual disease
                                        R0
                                        R1< 0.0001
                                        R2
Therapy
                                        surgery Primary
                                        NACT0.012
DOI: https://doi.org/10.1515/raon-2016-0034 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 341 - 346
Submitted on: May 29, 2015
|
Accepted on: Sep 5, 2015
|
Published on: Jul 19, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Erik Škof, Sebastjan Merlo, Gasper Pilko, Borut Kobal, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.